Authors:
FRYDMAN A
VASSEUR J
MOUREH J
SIONNEAU M
THARRAULT P
Citation: A. Frydman et al., COMPARISON OF SUPERHEATED STEAM AND AIR OPERATED SPRAY DRYERS USING COMPUTATIONAL FLUID-DYNAMICS, Drying technology, 16(7), 1998, pp. 1305-1338
Citation: A. Frydman et Z. Ovadyahu, CHARGE-TRANSPORT THROUGH SUPERCONDUCTOR ANDERSON-INSULATOR INTERFACES/, Physical review. B, Condensed matter, 55(14), 1997, pp. 9047-9057
Authors:
NORONHA FB
FRYDMAN A
ARANDA DAG
PEREZ C
SOARES RR
MORAWEK B
CASTNER D
CAMPBELL CT
FRETY R
SCHMAL M
Citation: Fb. Noronha et al., THE PROMOTING EFFECT OF NOBLE-METAL ADDITION ON NIOBIA-SUPPORTED COBALT CATALYSTS, Catalysis today, 28(1-2), 1996, pp. 147-157
Authors:
APPEL LG
FRYDMAN A
PEREZ CAC
EON JG
CASTNER DG
CAMPBELL CT
SCHMAL M
Citation: Lg. Appel et al., XPS STUDIES ON CE AL2O3 AND ON CO-RH/NB2O5 CATALYSTS (VOL 192, PG 477, 1995)/, Physica status solidi. b, Basic research, 198(2), 1996, pp. 17-17
Citation: A. Frydman, LOW-MOLECULAR-WEIGHT HEPARINS - AN OVERVIEW OF THEIR PHARMACODYNAMICS, PHARMACOKINETICS AND METABOLISM IN HUMANS, Haemostasis, 26, 1996, pp. 24-38
Authors:
COLLIGNON F
SAHA A
OZOUX ML
FURMAN WK
SPIRO I
MCCORMACK A
CAPLAIN H
THEBAULT JJ
FRYDMAN A
BOUTHIER J
Citation: F. Collignon et al., COMPARATIVE DISPOSITION OF ENOXAPARIN IN TOTAL HIP-REPLACEMENT (THR) PATIENTS AND IN HEALTHY-VOLUNTEERS GIVEN SUBCUTANEOUSLY A 30 MG ENOXAPARIN DOSE 2 TIMES DAY FOR 7 DAYS, Thrombosis and haemostasis, 73(6), 1995, pp. 970-970
Authors:
FRYDMAN A
BARA L
COLLIGNON F
OZOUX ML
LEROUX Y
COURNOT A
THEBAULT JJ
CAPLAIN H
SAMAMA MM
Citation: A. Frydman et al., DO THE PHARMACOKINETICS OF ENOXAPARIN REMAIN STABLE AND LINEAR IN THERANGE OF DOSES FOR PREVENTION UP TO THE RANGE OF DOSES FOR TREATMENT OF VENOUS THROMBOEMBOLIC DISEASES, Thrombosis and haemostasis, 73(6), 1995, pp. 971-971
Authors:
FRYDMAN A
COLLIGNON F
OZOUX ML
SPIRO T
ROMARY MC
GUIMART C
LEROUX Y
Citation: A. Frydman et al., A POPULATION APPROACH TO ENOXAPARIN DISPOSITION PROFILE IN A MULTICENTER CLINICAL-TRIAL INVOLVING TOTAL KNEE REPLACEMENT PATIENTS GIVEN SUBCUTANEOUSLY THE 30-MG BID DOSE REGIMEN, Thrombosis and haemostasis, 73(6), 1995, pp. 971-971
Authors:
COLLIGNON F
FRYDMAN A
CAPLAIN H
OZOUX ML
LEROUX Y
BOUTHIER J
THEBAULT JJ
Citation: F. Collignon et al., COMPARISON OF THE PHARMACOKINETIC PROFILES OF 3 LOW-MOLECULAR-MASS HEPARINS - DALTEPARIN, ENOXAPARIN AND NADROPARIN - ADMINISTERED SUBCUTANEOUSLY IN HEALTHY-VOLUNTEERS (DOSES FOR PREVENTION OF THROMBOEMBOLISM), Thrombosis and haemostasis, 73(4), 1995, pp. 630-640
Citation: A. Frydman et Z. Ovadyahu, SPIN AND QUANTUM INTERFERENCE EFFECTS IN HOPPING CONDUCTIVITY, Solid state communications, 94(9), 1995, pp. 745-749
Authors:
FRYDMAN A
CASTNER DG
SCHMAL M
CAMPBELL CT
Citation: A. Frydman et al., A METHOD FOR ACCURATE QUANTITATIVE XPS ANALYSIS OF MULTIMETALLIC OR MULTIPHASE CATALYSTS ON SUPPORT PARTICLES, Journal of catalysis, 157(1), 1995, pp. 133-144
Authors:
FRYDMAN A
CASTNER DG
SCHMAL M
CAMPBELL CT
Citation: A. Frydman et al., PARTICLE AND PHASE THICKNESSES FROM XPS ANALYSIS OF SUPPORTED BIMETALLIC CATALYSTS - CALCINED CO-RH NB2O5/, Journal of catalysis, 152(1), 1995, pp. 164-178
Authors:
MONTAY G
BRUNO R
VERGNIOL JC
EBMEIER M
LEROUX Y
GUIMART C
FRYDMAN A
CHASSARD D
THEBAULT J
Citation: G. Montay et al., PHARMACOKINETICS OF SPARFLOXACIN IN HUMANS AFTER SINGLE ORAL-ADMINISTRATION AT DOSES OF 200-MG, 400-MG, 600-MG, AND 800-MG, Journal of clinical pharmacology, 34(11), 1994, pp. 1071-1076
Authors:
LELIBOUX A
TEULE M
FRYDMAN A
OOSTERHUIS B
JONKMAN JHG
Citation: A. Leliboux et al., EFFECT OF DIET ON THE SINGLE-DOSE AND MULTIPLE-DOSE PHARMACOKINETICS OF SUSTAINED-RELEASE KETOPROFEN, European Journal of Clinical Pharmacology, 47(4), 1994, pp. 361-366
Authors:
CHEVALIER P
ROUILLARD C
MONTAY G
FRYDMAN A
Citation: P. Chevalier et al., APRIKALIM - RADIOIMMUNOASSAY AND PHARMACOKINETIC STUDIES IN MOUSE, MONKEY, AND DOG, Journal of pharmaceutical sciences, 83(3), 1994, pp. 372-378
Authors:
BRUNO R
DORR MB
MONTAY G
FRYDMAN A
THIS F
FUMOLEAU P
KAY S
KAVANAGH GH
BURRIS HA
RIGAS JR
BAYSSAS M
Citation: R. Bruno et al., DESIGN AND PROSPECTIVE IMPLEMENTATION OF POPULATION PHARMACOKINETIC STUDIES DURING THE DEVELOPMENT OF DOCETAXEL (D) (RP-56976) - A NEW ANTICANCER DRUG, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 161-161
Citation: Rr. Soares et al., EFFECT OF PREPARATION METHOD ON 5-PERCENT CO NB205 IN FISCHER-TROPSCHSYNTESIS (FTS)/, Catalysis today, 16(3-4), 1993, pp. 361-370
Authors:
FRYDMAN A
BOUVIER JL
ROBINET A
MOREL C
TAIEB H
YVENOU L
KAPLAN P
BOUTHIER J
Citation: A. Frydman et al., LACK OF INTERACTION ON THE HEMOSTASIS BALANCE BETWEEN NICORANDIL AND ACENOCOUMAROL IN ISCHEMIC-HEART-DISEASE PATIENTS, Thrombosis and haemostasis, 69(6), 1993, pp. 678-678